Stent Graft Balloon Catheter Market Report 2026

The stent graft balloon catheter market size has grown strongly in recent years. It will grow from $2.77 billion in 2025 to $3.05 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to rising prevalence of cardiovascular and vascular disorders, increasing geriatric population prone to aneurysms and arterial diseases, growing adoption of minimally invasive surgical techniques, expansion of hospital-based interventional cardiology procedures, technological advancements in catheter-based vascular treatment devices.

The stent graft balloon catheter market size is expected to see rapid growth in the next few years. It will grow to $4.47 billion by 2030 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to increasing demand for advanced endovascular repair procedures, rising investment in next-generation vascular intervention technologies, growing integration of imaging and navigation systems in catheter procedures, expansion of outpatient vascular treatment centers, increasing development of flexible and high-performance balloon catheter materials. Major trends in the forecast period include increasing adoption of minimally invasive endovascular procedures, rising demand for low profile balloon catheter systems, growing preference for high pressure stent graft balloon catheters in complex vascular procedures, expansion of drug coated balloon catheter applications, increasing utilization of precision-guided vascular intervention devices.

The rising prevalence of cardiovascular diseases is expected to propel the growth of the stent graft balloon catheter market going forward. Cardiovascular diseases refer to a category of disorders that impact the heart and blood vessels, including conditions such as coronary artery disease, peripheral artery disease, and aortic aneurysms that limit or obstruct normal blood circulation. The increasing prevalence of cardiovascular diseases is mainly attributed to unhealthy dietary patterns, which progressively impair normal cardiovascular function and contribute to a greater burden of heart-related disorders among the population. Stent graft balloon catheters are utilized in cardiovascular diseases by facilitating the accurate placement and expansion of stent grafts to open narrowed or weakened blood vessels, thereby restoring proper blood circulation and maintaining vessel integrity. For instance, in March 2025, according to the Joint Strategic Needs Assessment, the number of deaths caused by cardiovascular disease (CVD) reached 185 in 2023, compared to 178 recorded in 2022. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the stent graft balloon catheter market.

The expanding geriatric population is expected to propel the growth of the stent graft balloon catheter market going forward. The geriatric population refers to the group of individuals generally aged 65 years and above who are considered elderly and may undergo age-related physical, physiological, and social changes. The growth of the geriatric population is mainly driven by rising life expectancy, supported by advancements in healthcare and improved disease management, enabling a larger number of people to live into older age. Stent graft balloon catheters support the geriatric population by enabling accurate deployment and expansion of stent grafts to manage age-related vascular conditions such as aneurysms and arterial blockages, enhancing blood flow and lowering the risk of life-threatening complications. For instance, in February 2025, according to the World Health Organization, the global population of individuals aged 60 years and older is rapidly increasing due to longer life expectancy and declining birth rates, with older adults projected to outnumber younger age groups in many regions by 2030. Therefore, the growing geriatric population is driving the growth of the stent graft balloon catheter market.

The rising healthcare expenditure is expected to propel the growth of the stent graft balloon catheter market going forward. Healthcare expenditure refers to the total financial resources allocated toward healthcare services, including medical treatments, diagnostic procedures, medications, and preventive care. Healthcare expenditure is increasing due to population aging, as older populations experience higher rates of chronic illnesses, require more frequent healthcare services, and often depend on long-term treatments, thereby increasing overall healthcare costs. Rising healthcare expenditure supports greater investment in advanced medical technologies and minimally invasive vascular procedures, accelerating the adoption and utilization of stent graft balloon catheters for the effective treatment of complex cardiovascular and vascular disorders. For instance, in January 2026, according to the Centers for Medicare & Medicaid Services, in 2024, national health expenditure (NHE) grew by 7.2% to $5.3 trillion, averaging $15,474 per person and accounting for 18% of GDP. Therefore, increasing healthcare expenditure is driving the growth of the stent graft balloon catheter market.

Major companies operating in the stent graft balloon catheter market are Abbott Laboratories, Boston Scientific Corporation, Shandong Weigao Group Medical Polymer Company Limited, B. Braun Melsungen AG, Terumo Corporation, Meril Life Sciences Pvt. Ltd., Nordson Corporation, Cook Medical LLC, Lepu Medical Technology Co Ltd., MicroPort Scientific Corporation, Biomerics LLC, Freudenberg Group, Teleflex Medical OEM, Putnam Plastics Corporation, W. L. Gore & Associates Inc., Alvimedica Medikal Ürünler Sanayi ve Ticaret A. Ş., Natec Medical Ltd., Bentley InnoMed GmbH, Cardionovum GmbH, AndraTec GmbH.

North America was the largest region in the stent graft balloon catheter market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stent graft balloon catheter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the stent graft balloon catheter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The stent graft balloon catheter market consists of sales of non-compliant balloon catheters, occlusion balloon catheters, aortic stent graft molding balloons, drug-coated balloon catheters, and semi-compliant balloon catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.